Owners, management and financials
CVR: 39713918
Not available
Net result: DKK -29,995
AGC Biologics A/S (100%)
CVR · view owners
Kasper Møller
Board: Alberto Santagostino (chair) and 2 members
CVR · view management
Active
Founded 25 June 2018
CVR · view overview
0 employees
Annual report 2025 · average
Director role ended: Lasse Skov Kristensen
CVR · 21/08/2025
View the full event history
AGC Biologics Copenhagen ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Kasper Møller. The board consists of Alberto Santagostino (chair), Mai Iwaya and Tadashi Murano. The company is owned by AGC Biologics A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -29,995 compared with DKK -20,559 the year before. Equity in the 2025 report amounted to DKK 118,820.
Virksomhedens formål er handel og industri.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -30K | 155K | 119K | 0 | |
| 202401/01/2024 – 31/12/2024 | - | -21K | 181K | 149K | - | |
| 202301/01/2023 – 31/12/2023 | - | -24K | 198K | 169K | - | |
| 202201/01/2022 – 31/12/2022 | - | -22K | 221K | 193K | 0 | |
| 202101/01/2021 – 31/12/2021 | -28K | -22K | 228K | 215K | 0 | |
| 202001/01/2020 – 31/12/2020 | - | -26K | 50K | 37K | 0 | |
| 201901/01/2019 – 31/12/2019 | 0 | -15K | 66K | 63K | 0 |
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of AGC Biologics Copenhagen ApS is 39713918.
AGC Biologics Copenhagen ApS is owned by AGC Biologics A/S.
The management of AGC Biologics Copenhagen ApS consists of Kasper Møller.
The board of AGC Biologics Copenhagen ApS consists of Alberto Santagostino, Mai Iwaya and Tadashi Murano, with Alberto Santagostino as chair.
AGC Biologics Copenhagen ApS had an average of 0 employees in the 2025 financial year according to the annual report.
AGC Biologics Copenhagen ApS was founded on 25 June 2018.
Claim this page to add your logo and social links. Free to get started.
AGC Biologics Copenhagen ApS has published its annual report for 2025. The net result was DKK -29,995.
As of August 21, 2025, Lasse Skov Kristensen has stepped down as director of AGC Biologics Copenhagen ApS.
AGC Biologics Copenhagen ApS has published its annual report for 2024. The net result was DKK -20,559.
As of May 7, 2025, Lasse Skov Kristensen is registered as director of AGC Biologics Copenhagen ApS.
As of April 18, 2025, AGC Biologics A/S is registered as an owner of AGC Biologics Copenhagen ApS with an ownership share of 100%.
As of March 14, 2025, Alberto Santagostino has joined the board of directors of AGC Biologics Copenhagen ApS.
As of March 14, 2025, Mai Iwaya has joined the board of directors of AGC Biologics Copenhagen ApS.
As of March 14, 2025, Akira Nakamura has left the board of directors of AGC Biologics Copenhagen ApS.
As of November 30, 2024, Lasse Fuglsang Pedersen has stepped down as director of AGC Biologics Copenhagen ApS.
AGC Biologics Copenhagen ApS has published its annual report for 2023. The net result was DKK -23,834.
As of July 5, 2024, Patricio Ezequiel Massera has left the board of directors of AGC Biologics Copenhagen ApS.
As of January 8, 2024, Tadashi Murano has joined the board of directors of AGC Biologics Copenhagen ApS.
As of January 8, 2024, Noriyuki Komuro has left the board of directors of AGC Biologics Copenhagen ApS.
AGC Biologics Copenhagen ApS has published its annual report for 2022. The net result was DKK -22,187.
As of September 1, 2022, Akira Nakamura has joined the board of directors of AGC Biologics Copenhagen ApS.
As of September 1, 2022, Hiroshi Nishimura has left the board of directors of AGC Biologics Copenhagen ApS.
AGC Biologics Copenhagen ApS has published its annual report for 2021. Gross profit came to DKK -28,010, and the net result was DKK -21,848.
AGC Biologics Copenhagen ApS has published its annual report for 2020. The net result was DKK -25,944.
AGC Biologics Copenhagen ApS has published its annual report for 2019. Gross profit came to DKK 0, and the net result was DKK -15,114.
As of May 19, 2020, Patricio Ezequiel Massera has joined the board of directors of AGC Biologics Copenhagen ApS.
AGC Biologics Copenhagen ApS has published its interim report for the period June 25, 2018 to December 31, 2018.
As of April 25, 2019, Gustavo Fabio Mahler has left the board of directors of AGC Biologics Copenhagen ApS.
As of June 25, 2018, KPMG P/S has been appointed auditor of AGC Biologics Copenhagen ApS.
As of June 25, 2018, Hiroshi Nishimura has joined the board of directors of AGC Biologics Copenhagen ApS.
As of June 25, 2018, Gustavo Fabio Mahler has joined the board of directors of AGC Biologics Copenhagen ApS.
As of June 25, 2018, Noriyuki Komuro has joined the board of directors of AGC Biologics Copenhagen ApS.
As of June 25, 2018, Lasse Fuglsang Pedersen is registered as director of AGC Biologics Copenhagen ApS.
As of June 25, 2018, Kasper Møller is registered as director of AGC Biologics Copenhagen ApS.
AGC Biologics Copenhagen ApS was founded on June 25, 2018.
Companies in the same industry and area
CVR 25275055
CVR 33071140
CVR 15183292
CVR 37317047
CVR 30192664
